Daniel P Cahill

A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy.

Tracy T Batchelor, Richard Lugg, Andrew Menzies, 2006, Cancer research.

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

Marcela V Maus, William T Curry, Brian V Nahed, 2019, Nature Biotechnology.

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

Rebecca A Betensky, Matija Snuderl, David N Louis, 2011, Cancer cell.

Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma

Yuchen Jiao, Bert Vogelstein, Chetan Bettegowda, 2011, Science.

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Rebecca A Betensky, Tracy T Batchelor, Patrick J Codd, 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Tracy T Batchelor, Thomas Benner, A Gregory Sorensen, 2007, Cancer cell.